nafronyl has been researched along with endothelin-1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jagroop, IA; Mikhailidis, DP | 1 |
| Endemann, D; Fischereder, M; Ittner, KP; Kammerl, MC; Krämer, BK; Schweda, F; Stubanus, M | 1 |
| Calvert, RC; Dashwood, MR; Khan, MA; Mikhailidis, DP; Morgan, RJ; Mumtaz, FH; Thompson, CS | 1 |
3 other study(ies) available for nafronyl and endothelin-1
| Article | Year |
|---|---|
Effect of endothelin-1 on human platelet shape change: reversal of activation by naftidrofuryl.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Cell Size; Endothelin Receptor Antagonists; Endothelin-1; Female; Humans; Male; Middle Aged; Nafronyl; Platelet Activation; Serotonin; Serotonin Antagonists; Vasodilator Agents | 2000 |
Naftidrofuryl exerts antiserotonergic but no endothelin-receptor blocking effects in AS4.1 cells, juxtaglomerular cells and isolated perfused rat kidneys.
Topics: Animals; Calcium; Cells, Cultured; Endothelin-1; Endothelin-3; Kidney; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Nafronyl; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Renal Circulation; Renin; Serotonin; Serotonin Antagonists; Vasoconstriction | 2002 |
Reduction of endothelin-1 binding and inhibition of endothelin-1-mediated detrusor contraction by naftidrofuryl.
Topics: Animals; Autoradiography; Binding Sites; Depression, Chemical; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; In Vitro Techniques; Muscle Contraction; Nafronyl; Oligopeptides; Peptides, Cyclic; Piperidines; Protein Binding; Rabbits; Receptor, Endothelin A; Receptor, Endothelin B; Urinary Bladder; Vasodilator Agents | 2002 |